Brain Imaging | Medical XPRT
Articles & Whitepapers
-
Cercare Perfusion Reveals Microvascular Changes in COVID-19 - Case Study
Introduction Neurologic complications are frequently reported in COVID-19, but our understanding of their pathophysiologic causes and neuroanatomical correlates is limited. While several structural brain imaging findings have been reported in COVID-19, including non-spherical signal abnormalities on Susceptibility-Weighted Imaging (SWI), conventional perfusion imaging has not provided consistent ...
-
SpinTech MRI Earns FDA 510(k) Clearance for Rapid, Quantitative Brain-Imaging Technology
The US Food and Drug Administration (FDA) has given 510(k) clearance to SpinTech MRI’s latest magnetic resonance imaging software device, STAGE (STrategically Acquired Gradient Echo), a ...
News
-
Pivalate’s additional data released from positive Phase II imaging trial in brain metastases
Sydney, Australia - November 23, 2022 - Radiopharm Theranostics (ASX:RAD), a developer of a world-class platform of radiopharmaceutical products for both diagnostic and therapeutic uses, is pleased to announce that Imperial College London has ...
SpinTech CEO Presents STAGE at MedTech Strategist Innovation San Francisco 2021
Oxford Brain Diagnostics’ grey matter quality measure selected as secondary outcome for Alzheimer’s Phase 2 clinical trial
Sosei Heptares and Kallyope Enter Collaboration to Identify and Validate Novel Gastrointestinal GPCR Targets for Drug Discovery
Longeveron Publishes Peer Reviewed Study of Phase 1 Trial Results of Lomecel-B for Alzheimer’s Disease in Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association
Equipment & Solutions
-
Showcase
Biomarker
A wide-available rapid biochemical test would add advantages in the pre-hospital triage and management of stroke patients, allowing to begin time limited treatment options as reperfusion therapies (i.e. tPA treatment) at the admission or event at the ambulance and therefore improving enormously the rates of recovery of ischemic stroke patients.